Skip to main content

Table 1 General characteristics of the study subjects

From: Effect of probiotic supplementation along with calorie restriction on metabolic endotoxemia, and inflammation markers in coronary artery disease patients: a double blind placebo controlled randomized clinical trial

Variable

Probiotic group (n = 22)

Placebo group (n = 22)

P-value

Age (years)a

56.70 ± 9.10

57.10 ± 7.80

0.876d

Weight (kg)a at study baseline

75.60 ± 12.30

79.20 ± 12.10

0.390d

Weight (kg)a after intervention

72.35 ± 12.40

77.54 ± 11.20

0.156

Smoking

5 (22)

4 (18)

0.431c

Ejection Fraction (%)

37.0 (7.1)

38.31 (6.7)

0.527

Non-Smoking n(%)

17 (78)

18 (82)

0.431c

PAL n(%)

  

0.491c

Low

7 (31)

2 (10)

 

Moderate

13 (59)

19 (86)

 

High

2 (10)

1 (4)

 

Adverse Effects n(%)

2 (9)

1 (4.5)

0.488

Compliance Rate (%)d

85

80

0.721

  1. PAL physical activity level, MD Mean/Median of difference
  2. aValues are expressed as mean (SD)
  3. b- Values are expressed as frequency (%)
  4. cChi-square test
  5. dIndependent samples t-test